These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 1195466)
1. Antigenic deletion and prognosis of patients with stage A transitional cell bladder carcinoma. Decenzo JM; Howard P; Irish CE J Urol; 1975 Dec; 114(6):874-8. PubMed ID: 1195466 [TBL] [Abstract][Full Text] [Related]
2. Tissue blood-group antigens and prognosis in low stage transitional cell carcinoma of the bladder. Lange PH; Limas C; Fraley EE J Urol; 1978 Jan; 119(1):52-5. PubMed ID: 621815 [TBL] [Abstract][Full Text] [Related]
3. Blood group isoantigens ABO (H) in transitional carcinoma of the bladder: a clinicopathological study. Cuadrado E; Rodriguez-Trinidad A; Blasco E; Torrado J; Lopez Garcia JA; Arozena F J Urol; 1986 Feb; 135(2):409-15. PubMed ID: 3511295 [TBL] [Abstract][Full Text] [Related]
4. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. IV. Correlation with Thomsen-Friedenreich antigen and CEA]. Nasu Y; Kumon H; Matsumura Y; Ohmori H Nihon Hinyokika Gakkai Zasshi; 1986 Sep; 77(9):1511-8. PubMed ID: 3807094 [No Abstract] [Full Text] [Related]
5. Prediction of bladder tumor invasion with the mixed cell agglutination test. Johnson JD; Lamm DL J Urol; 1980 Jan; 123(1):25-8. PubMed ID: 7351715 [TBL] [Abstract][Full Text] [Related]
6. The cell surface antigen A, B or O(H) as an indicator of malignant potential in stage A bladder carcinoma: preliminary report. Bergman S; Javadpour N J Urol; 1978 Jan; 119(1):49-51. PubMed ID: 621814 [TBL] [Abstract][Full Text] [Related]
7. Immunologic indicators of prognosis in bladder cancer: the importance of cell surface antigens. Richie JP; Blute RD; Waisman J J Urol; 1980 Jan; 123(1):22-4. PubMed ID: 6985979 [TBL] [Abstract][Full Text] [Related]
12. Red cell surface antigen and its relationship to survival of patients with transitional cell carcinoma of the bladder. Askari A; Colmenares E; Saberi A; Jarman WD J Urol; 1981 Feb; 125(2):182-4. PubMed ID: 7206050 [TBL] [Abstract][Full Text] [Related]
13. [Studies on blood group isoantigens in uroepithelium. I. Determination of isoantigens in non-malignant epithelium of tumor-bearing bladder]. Abe R Nihon Hinyokika Gakkai Zasshi; 1985 Jul; 76(7):1049-58. PubMed ID: 4079195 [No Abstract] [Full Text] [Related]
14. The prognostic value of cell surface antigens in low grade, non-invasive, transitional cell carcinoma of the bladder. Young AK; Hammond E; Middleton AW J Urol; 1979 Oct; 122(4):462-4. PubMed ID: 480485 [TBL] [Abstract][Full Text] [Related]
15. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. II. Results of a long-term follow-up and technical problems]. Kumon H; Nasu Y; Matsumura Y; Ohmori H Nihon Hinyokika Gakkai Zasshi; 1984 May; 75(5):731-8. PubMed ID: 6492527 [No Abstract] [Full Text] [Related]
16. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. III. Detection by PAP method and a classification of staining pattern]. Nasu Y; Kumon H; Matsumura Y; Ohmori H Nihon Hinyokika Gakkai Zasshi; 1984 May; 75(5):739-43. PubMed ID: 6208400 [No Abstract] [Full Text] [Related]
17. Cell surface A, B, or O(H) blood group antigens as an indicator of malignant potential in stage A bladder carcinoma. Newman AJ; Carlton CE; Johnson S J Urol; 1980 Jul; 124(1):27-9. PubMed ID: 7411715 [TBL] [Abstract][Full Text] [Related]
18. A, B, O (H) antigenic determinants in superficial transitional cell tumors of bladder. Selli C; Cozzolino F; Vercelli D; Mincione GP Urology; 1983 Feb; 21(2):132-4. PubMed ID: 6186066 [TBL] [Abstract][Full Text] [Related]
19. ABO (H) blood group antigens and carcinoembryonic antigens as indicators of malignant potential in patients with transitional cell carcinoma of the bladder. Nakatsu H; Kobayashi I; Onishi Y; Igawa M; Ito H; Tahara E; Nihira H J Urol; 1984 Feb; 131(2):252-7. PubMed ID: 6366250 [TBL] [Abstract][Full Text] [Related]
20. Expression of ABH blood group isoantigen as a prognostic factor in transitional cell bladder carcinoma. Malmström PU; Busch C; Norlen BJ; Andersson B Scand J Urol Nephrol; 1988; 22(4):265-70. PubMed ID: 3238331 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]